Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

NCT04788758 | Completed DMC

• 2 other identifiers: 19E.925JT 14176
• Study Type: interventional
• Target: 76
• Locations: 1 country
• Sites: 1

Brief Summary

This phase II trial investigates how easy it is to incorporate a nursing led geriatric assessment screening tool into a busy oncology practice, in order to identify at-risk older adults being evaluated for cancer treatment. This screening tool may help identify at-risk patients who can be referred for more in depth assessment, allowing for the creation of an individualized treatment plan that puts the patient's safety and personal goals as a priority.

Conditions

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm

Outcome Measures

Primary Outcomes (7)

• Overall assessment score: Pre

  The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.

  Before self-administered learning module

• Overall assessment score: Post

  The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.

  After self-administered learning module

• Number of patients screened

  Will be summarized by sample means, standard deviations and/or percentages.

  Up to 30 months

• Number of patients who refused

  Will be summarized by sample means, standard deviations and/or percentages.

  Up to 30 months

• Time it took to screen

  Will be summarized by sample means, standard deviations and/or percentages.

  Up to 30 months

• Number of referrals to Senior Adult Oncology Center (SAOC)

  Will be summarized by sample means, standard deviations and/or percentages.

  Up to 30 months

• Number of completed SAOC visits

  Will be summarized by sample means, standard deviations and/or percentages.

  Up to 30 months

Secondary Outcomes (1)

• Positive predictive value of the G8

  Up to 30 months

Study Arms (1)

Health Services Research (G8 screening tool, referral)

EXPERIMENTAL

PHASE I: Registered Nurses receive training on how to administer the G8 screening tool utilizing an Epic flowsheet to patients using a self-directed education module and by direct assessment by a geriatrician. PHASE II: Patients complete the G8 screening tool questionnaire over 10 minutes as part of their standard initial assessment, and their answers are entered into their EHR flowsheet. Patients who score =\< 14 on the G8 are referred for a CGA at SAOC, and these patients and their medical oncologists are made aware. Within 2 weeks of the initial screening, the results are communicated with the patient and medical oncologist at a 2-hour SAOC visit. Patients with a score of \> 15 on the G8 are made aware of their results without any referral generated.

Other: Educational Intervention; Other: Screening Questionnaire Administration; Other: Referral; Other: Questionnaire Administration

Interventions

Educational Intervention OTHER

Receive G8 screening tool administration training

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

Health Services Research (G8 screening tool, referral)

Screening Questionnaire Administration OTHER

Complete G8 screening tool

Health Services Research (G8 screening tool, referral)

Referral OTHER

Receive referral

Also known as: Referral, referral, Referred

Health Services Research (G8 screening tool, referral)

Questionnaire Administration OTHER

Ancillary studies

Health Services Research (G8 screening tool, referral)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• NURSES: Assigned to two designated cancer clinics at Sidney Kimmel Cancer Center (SKCC) Center City, the Renal Cell Carcinoma (RCC) and Lymphoma/myeloma clinics
• PATIENTS: 65 years and older
• PATIENTS: Diagnosis of cancer

You may not qualify if:

• PATIENTS: Inability to answer or have caregiver answer questions on screening tool

Sponsors & Collaborators

• Thomas Jefferson University: lead

Study Sites (1)

Thomas Jefefrson University

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Interventions

Early Intervention, Educational; Educational Status; Methods; Referral and Consultation

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Child Health Services; Community Health Services; Health Services; Health Care Facilities Workforce and Services; Preventive Health Services; Socioeconomic Factors; Population Characteristics; Investigative Techniques; Professional Practice; Organization and Administration; Health Services Administration

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 10, 2021
• First Posted: March 9, 2021
• Study Start: January 29, 2020
• Primary Completion: May 25, 2022
• Study Completion: May 25, 2022
• Last Updated: April 29, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)